Status:
COMPLETED
Study With a Topical Gel to Treat Common Warts in Adults
Lead Sponsor:
Graceway Pharmaceuticals, LLC
Conditions:
Warts
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The primary purpose of this study is to evaluate the effectiveness in adults of four different strengths of resiquimod gel applied to common wart(s) five times a week for four weeks. A second purpose...
Eligibility Criteria
Inclusion
- Diagnosis of common warts
- Two forms of birth control
Exclusion
- Pregnant or breast feeding
- Other types of warts, ie. plantar
- Currently participating in another clinical study
- Chronic viral hepatitis B or C
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT00117923
Start Date
August 1 2004
Last Update
February 19 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Medical Research Center
Portland, Oregon, United States, 97223